Analyst Reiterates Overweight Rating on Nano-X Imaging Post NVIDIA Investment News
InvestingFeb 15 10:02 ET
Nano X Imaging Analyst Ratings
BenzingaFeb 15 09:21 ET
Nano X Imaging Analyst Ratings
BenzingaJan 19 10:52 ET
Nano X Imaging Analyst Ratings
BenzingaNov 29, 2023 09:34 ET
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
BenzingaOct 3, 2023 09:36 ET
Nano X Imaging Analyst Ratings
BenzingaOct 3, 2023 09:33 ET
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
BenzingaSep 26, 2023 11:47 ET
Nano X Imaging Analyst Ratings
BenzingaSep 26, 2023 11:47 ET
Nano X Imaging Analyst Ratings
BenzingaSep 8, 2023 08:41 ET
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
BenzingaAug 22, 2023 11:39 ET
Nano X Imaging Analyst Ratings
BenzingaAug 22, 2023 11:38 ET
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
BenzingaAug 18, 2023 10:48 ET
Nano X Imaging Analyst Ratings
BenzingaAug 18, 2023 10:47 ET
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
BenzingaJun 14, 2023 11:17 ET
Watching Nano-X Imaging; Hearing Cantor Fitzgerald Says Co Won A Large Hospital Contract In Europe, Notably, ARC System At CHU University Hospital In Marrakech, Reiterating Its Overweight Rating And $30 Price Target
BenzingaJun 14, 2023 10:44 ET
Cantor Fitzgerald Adjusts Nano-X Imaging Price Target to $30 From $21, Maintains Overweight Rating
MT NewswiresMay 23, 2023 11:35 ET
No Data
No Data